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We are writing in response to the recent paper by Toegel
et al. (2008) Osteoarthritis and Cartilage1 comparing the
chondroprotective effects of glucosamine, curcumin and
diacerein in interleukin 1-beta (IL-1b)-stimulated C-28/I2
chondrocytes. It was with great interest that we noted the
authors’ ﬁndings of increased expression of cartilage-
speciﬁc genes in the presence of 5 mM glucosamine and
50 mM diacerein, with these concentrations effectively
antagonizing any IL-1b induced changes in matrix gene
transcription and cell proliferation. However, our attention
was drawn to the apparent cytotoxicity of the polyphenol
curcumin at 50 mM on C-28/I2 transformed chondrocytes.
Initially, these results appeared to be markedly different
from observations made in several laboratories where con-
centrations of curcumin, up to and including 100 mM, had no
effect on the viability of freshly isolated chondrocytes from
a number of species. However, our recent data suggests
that curcumin at 50 mM and above exerts cytotoxic effects
on primary chondrocytes.
We have been developing ex vivo cartilage explant
models for the purpose of screening various extracts.
One model assesses the effects of different compounds
on unstimulated, ‘normal’ cartilage cultured in media alone.
The other, an inﬂammatory model, assesses whether
these compounds exhibit any anti-catabolic activity by us-
ing IL-1b to induce catabolic changes similar to those ob-
served in osteoarthritis (OA). Using these models, we have
found that curcumin at concentrations between 0.1 mM and
100 mM does not alter the quantity of glycosaminoglycans
(GAGs) released from unstimulated cartilage explants
compared to their controls that received no curcumin treat-
ment. In the inﬂammatory model, we found that the IL-1b-
stimulated increase in GAG release was signiﬁcantly
reduced to levels found in unstimulated explants by the
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attenuated by curcumin concentrations as low as 3 mM
(unpublished observations). Explants are more appropriate
for studies of extracellular matrix turnover than monolayer
cultures of primary chondrocytes and transformed chon-
drocyte-like cell lines, due to the fact the chondrocytes
are being maintained in their natural physicochemical envi-
ronment in situ (the extracellular matrix of articular carti-
lage). Thus far, we have not observed any detrimental
effects of curcumin at high concentrations in the explants
we have tested. However, in monolayer cultures of equine
articular chondrocytes, we have observed cell death
between 50 mM and up to 100 mM which is in agreement
with the results of Toegel et al. Consequently, these
results are not in agreement with several studies using pri-
mary human chondrocytes3,4.
Initially, we surmised that the conﬂicting ﬁndings of pub-
lished work compared to the results of Toegel et al. could
be due to the differences between using primary chondro-
cytes and transformed chondrocyte cell lines. The cytotoxic
effects of curcumin are well documented with regard to its
pro-apoptotic effects in cancer cells and cancer cell
lines5e7. Indeed, this is the reason why this polyphenol
has been proposed as an anticancer chemotherapeutic
agent. There is a large body of scientiﬁc literature support-
ing the idea that curcumin exerts different effects on normal
cells and ‘transformed’ or immortalised cancer cells8. Thus
the apparent toxic effects of curcumin on the transformed
chondrocyte cell line C-28/I2 used in the Toegel study could
have been due to the known apoptosis-inducing effects of
curcumin on cancer and transformed cells in general. How-
ever, our recent observations suggest that high concentra-
tions of curcumin (i.e. 50 to 100 mM) are also toxic to
primary articular chondrocytes. In conclusion, we wish to
thank the authors for bringing this apparent toxicity of curcu-
min to our attention. Their observations are in agreement
with the literature on transformed cells, and we can now
conﬁrm that this is also the case with primary isolated,
non-transformed chondrocytes. Clearly further studies are
required in this area to establish the optimal physiological
concentration at which curcumin may exert beneﬁcial
effects on chondrocytes without cytotoxic sequelae. In addi-
tion it would be beneﬁcial to compare the effects of curcu-
min on chondrocyte function and viability across a number
of different species.
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